$2 egg-beater - low-cost centrifuge replacement - could save lives in developing countries
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases
Full Post: Alfuzosin fails to reduce symptoms in chronic prostatitis
Plastic tubing taped to a handheld egg-beater could save lives in developing countries, the Royal Society of Chemistry’s journal Lab on a Chip reports.
The low-cost centrifuge replacement can separate plasma from blood in minutes, which is used in tests to detect lethal infectious diseases responsible for half of all deaths in developing countries.
George Whitesides and colleagues at Harvard University, US, say the plasma obtained is easily good enough to use in tests to detect diseases such as Hepatitis B and cysticercosis.
“The object was to separate serum [plasma] from blood using readily-obtained materials in a resource-constrained environment,” explains Whitesides.
The equipment can be bought from shops for around two dollars. It needs no special training to use, no electricity or maintenance, and can be sterilised with boiling water and reused.
The user can even prepare several samples at once - just by taping more lengths of tubing to the beater.
Contrast this with the bulky, sensitive commercial centrifuges, costing thousands of dollars and requiring extensive operation training, and it’s easy to see how this development could save lives.
“This technique is simple and works remarkably well,” says Doug Weibel, an expert in microbiology at the University of Wisconsin-Madison, US. “This technique complements several other ’simple solutions’ that the Whitesides group has developed to tackle point-of-care diagnostics in resource-poor settings.
Bowel cancer screening is predicted to save over two and a half thousand lives every year in the UK by 2025, according to new research published in the Journal of Medical Screening*. The Cancer Research UK funded study, which looked at the impact home testing kits could have on mortality rates, showed that deaths from
Full Post: Bowel cancer screening set to save thousands of lives
A new “barcode chip” developed by researchers at the California Institute of Technology (Caltech) promises to revolutionize diagnostic medical testing. In less than 10 minutes, and using just a pinprick’s worth of blood, the chip can measure the concentrations of dozens of proteins, including those that herald the presence of diseases like cancer and heart
Full Post: Scientists develop ‘barcode chip’ to revolutionize diagnostic medical testing
Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome. This approach provides reliable test
Full Post: Roche’s new dual-target HIV-1 test approved in Europe
Using a simple, inexpensive test to detect radon gas seeping into homes could help prevent lung cancer and save thousands of lives, Acting Department of Environmental Protection Secretary John Hanger said today. “Homeowners can protect themselves and their families from this known carcinogen by using a test kit available for about $25 at hardware stores
Full Post: Simple test kit helps prevent lung cancer caused by radon
As World AIDS Day 2008 approaches, a coalition of hundreds of HIV/AIDS medical care providers and advocates, representing dozens of organizations, today sent a letter to Dr. Margaret Chan, Director General of the World Health Organization (WHO), urging an end to harmful single-dose HIV/AIDS treatment as a recommended treatment for expectant mothers and infants worldwide.
Full Post: AIDS advocates tell WHO: Stop harmful single-dose treatment for expectant mothers and infants